FDA Oversight Of Medical Products Remains A "High-Risk" Concern For GAO
This article was originally published in The Gray Sheet
Executive Summary
The Government Accountability Office is once again listing FDA's ability to ensure the safety and effectiveness of devices, drugs and other medical products on its roster of "high-risk" concerns.